It has been also associated with poor prognosis in GC patients [26] and in vitro and in vivo experiments found that FAT4 knockdown increases tumor growth and metastasis, mediated by the Wnt/β-catenin signaling pathway [22]. Here, FAT4 is linked to neoplasm.